Evaluation of the Effect of Healthy Lifestyle Intervention for Patients With Mild Cognitive Impairment

Launched by XUANWU HOSPITAL, BEIJING · Apr 16, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a comprehensive lifestyle program designed for people with mild cognitive impairment (MCI), which is a condition that can lead to more serious memory problems. The program includes four main activities: brain exercises, physical exercise, following the MIND diet (which focuses on healthy foods for brain health), and participating in group social activities. The goal is to see if this combination can help slow down cognitive decline, improve daily life skills, and enhance the overall quality of life for participants.

To be eligible for this study, individuals must have a diagnosis of mild cognitive impairment and have a caregiver who has been with them for at least six months. Participants should be willing to join the study and sign an agreement to do so. However, those who have received other cognitive therapies recently or have certain medical conditions, like serious heart issues or other major illnesses, may not be able to participate. During the study, participants can expect to engage in various activities aimed at improving their cognitive health, and their progress will be monitored through assessments that measure memory and mental function. If this trial proves successful, it could pave the way for larger studies and offer valuable insights into non-drug approaches for maintaining brain health in at-risk individuals.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. To meet the diagnostic criteria of MCI, refer to the diagnostic criteria of MCI in "2018 Chinese Guidelines for the Diagnosis and Treatment of Dementia and Cognitive Impairment (5) : Diagnosis and Treatment of Mild Cognitive Impairment".
• • 2. Have caregiver \> 6 months.
• • 3. Participate in the study voluntarily and sign the informed consent.
• Exclusion Criteria:
• • 1. Have received other cognitive intervention therapy recently (within 6 months).
• • 2. Diagnosis of functional encephalopathy or obvious mental disorders, such as Parkinson's disease, epilepsy, schizophrenia.
• • 3. Suffering from serious cardiovascular diseases, malignant tumors and other major physical diseases.
• • 4. Have visual, hearing, speech or limb dysfunction, unable to complete the test.
• • 5. Patients with chronic diseases who have special dietary needs or require special dietary management.